Super-selective Intra-arterial Repeated Infusion of Cetuximab for the Treatment of Newly Diagnosed Glioblastoma

NCT02861898 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

33

Enrollment

OTHER

Sponsor class

Conditions

Glioblastoma
Brain Cancer
Brain Neoplasm
Brain Tumor
Brain Neoplasm, Malignant
EGFR Gene Overexpression
GBM

Interventions

DRUG: Intra-arterial Cetuximab
DRUG: Intra-arterial Mannitol

Sponsor

Northwell Health